Filed: 8/14/2023ACC: 0001104659-23-090924
📋 What this filing means
ACUTA CAPITAL PARTNERS, LLC filed this quarterly 13F‑HR report disclosing 35 equity positions with a total reported market value of $147.60M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
35
Positions
$147.60M
Total AUM (reported)
17.67M
Total Shares
Allocation by class
COM$121.99M82.6%
COM NEW$10.45M7.1%
SPONSORED ADR$4.90M3.3%
COMMON STOCK$3.73M2.5%
ORDINARY SHARES$2.90M2.0%
SHARES$2.22M1.5%
SHS$1.40M0.9%
Portfolio Concentration
Top 3$48.25M32.7%
4–10$42.67M28.9%
11–25$49.03M33.2%
Rest$7.65M5.2%
Top 3 weight
32.7%
Top 10 weight
61.6%
Voting Authority Distribution
Total shares with voting rights: 17.67M
Sole
Full voting authority
17.67M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole35
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings35
Rows:
APELLIS PHARMACEUTICALS INC
SOLEShares297.60K
TypeSH
Market value$27.11M
18.37%
Sole
297.60K
Shared
0.00
None
0.00
AADI BIOSCIENCES INC
SOLEShares1.85M
TypeSH
Market value$12.65M
8.57%
Sole
1.85M
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares970K
TypeSH
Market value$8.49M
5.75%
Sole
970K
Shared
0.00
None
0.00
KURA ONCOLOGY INC. COMMON STOCK
SOLEShares709.12K
TypeSH
Market value$7.50M
5.08%
Sole
709.12K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares299.84K
TypeSH
Market value$6.28M
4.25%
Sole
299.84K
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares139.50K
TypeSH
Market value$6.19M
4.20%
Sole
139.50K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares122.17K
TypeSH
Market value$6.10M
4.13%
Sole
122.17K
Shared
0.00
None
0.00
ROCKET PHARMACEUTICALS INC
SOLEShares306.19K
TypeSH
Market value$6.08M
4.12%
Sole
306.19K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares224.71K
TypeSH
Market value$5.35M
3.62%
Sole
224.71K
Shared
0.00
None
0.00
IVERIC BIO INC
SOLEShares131.45K
TypeSH
Market value$5.17M
3.50%
Sole
131.45K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares12.57K
TypeSH
Market value$4.90M
3.32%
Sole
12.57K
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares4.25M
TypeSH
Market value$4.89M
3.31%
Sole
4.25M
Shared
0.00
None
0.00
VENTYX BIOSCIENCES INC
SOLEShares147.32K
TypeSH
Market value$4.83M
3.27%
Sole
147.32K
Shared
0.00
None
0.00
CYMABAY THERAPEUTICS INC. COMMON STOCK
SOLEShares430K
TypeSH
Market value$4.71M
3.19%
Sole
430K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC
SOLEShares122.34K
TypeSH
Market value$4.15M
2.81%
Sole
122.34K
Shared
0.00
None
0.00
CLENE INC
SOLEShares4.24M
TypeSH
Market value$3.73M
2.53%
Sole
4.24M
Shared
0.00
None
0.00
IKENA ONCOLOGY INC
SOLEShares558K
TypeSH
Market value$3.66M
2.48%
Sole
558K
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares382K
TypeSH
Market value$3.32M
2.25%
Sole
382K
Shared
0.00
None
0.00
GH RESEARCH PLC
SOLEShares244.83K
TypeSH
Market value$2.90M
1.97%
Sole
244.83K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares141.75K
TypeSH
Market value$2.69M
1.82%
Sole
141.75K
Shared
0.00
None
0.00
VERASTEM INC
SOLEShares300K
TypeSH
Market value$2.23M
1.51%
Sole
300K
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares220K
TypeSH
Market value$2.22M
1.50%
Sole
220K
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares104.50K
TypeSH
Market value$2.13M
1.44%
Sole
104.50K
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares44.69K
TypeSH
Market value$1.40M
0.95%
Sole
44.69K
Shared
0.00
None
0.00
ACLARIS THERAPEUTICS
SOLEShares121.69K
TypeSH
Market value$1.26M
0.85%
Sole
121.69K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
APELLIS PHARMACEUTICALS INCSOLE | COM | 297.60K | SH | $27.11M 18.37% | 297.60K | 0.00 | 0.00 |
AADI BIOSCIENCES INCSOLE | COM | 1.85M | SH | $12.65M 8.57% | 1.85M | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 970K | SH | $8.49M 5.75% | 970K | 0.00 | 0.00 |
KURA ONCOLOGY INC. COMMON STOCKSOLE | COM | 709.12K | SH | $7.50M 5.08% | 709.12K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 299.84K | SH | $6.28M 4.25% | 299.84K | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 139.50K | SH | $6.19M 4.20% | 139.50K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 122.17K | SH | $6.10M 4.13% | 122.17K | 0.00 | 0.00 |
ROCKET PHARMACEUTICALS INCSOLE | COM | 306.19K | SH | $6.08M 4.12% | 306.19K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 224.71K | SH | $5.35M 3.62% | 224.71K | 0.00 | 0.00 |
IVERIC BIO INCSOLE | COM | 131.45K | SH | $5.17M 3.50% | 131.45K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 12.57K | SH | $4.90M 3.32% | 12.57K | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM | 4.25M | SH | $4.89M 3.31% | 4.25M | 0.00 | 0.00 |
VENTYX BIOSCIENCES INCSOLE | COM | 147.32K | SH | $4.83M 3.27% | 147.32K | 0.00 | 0.00 |
CYMABAY THERAPEUTICS INC. COMMON STOCKSOLE | COM | 430K | SH | $4.71M 3.19% | 430K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INCSOLE | COM NEW | 122.34K | SH | $4.15M 2.81% | 122.34K | 0.00 | 0.00 |
CLENE INCSOLE | COMMON STOCK | 4.24M | SH | $3.73M 2.53% | 4.24M | 0.00 | 0.00 |
IKENA ONCOLOGY INCSOLE | COM | 558K | SH | $3.66M 2.48% | 558K | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 382K | SH | $3.32M 2.25% | 382K | 0.00 | 0.00 |
GH RESEARCH PLCSOLE | ORDINARY SHARES | 244.83K | SH | $2.90M 1.97% | 244.83K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 141.75K | SH | $2.69M 1.82% | 141.75K | 0.00 | 0.00 |
VERASTEM INCSOLE | COM NEW | 300K | SH | $2.23M 1.51% | 300K | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHARES | 220K | SH | $2.22M 1.50% | 220K | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 104.50K | SH | $2.13M 1.44% | 104.50K | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 44.69K | SH | $1.40M 0.95% | 44.69K | 0.00 | 0.00 |
ACLARIS THERAPEUTICSSOLE | COM | 121.69K | SH | $1.26M 0.85% | 121.69K | 0.00 | 0.00 |
Page 1 of 2